Total Clarity Wealth Management’s Lucid Diagnostics LUCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-500
Closed -$1K 653
2022
Q2
$1K Buy
+500
New +$1.11K ﹤0.01% 975

Other funds holding LUCD

Total Clarity Wealth Management's LUCD Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Lucid Diagnostics (LUCD) in Q3 2022, closing a stake of 500 shares — an estimated $1K sold.

Total Clarity Wealth Management first reported a position in LUCD in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 23 funds tracked by Wall St. Rank hold LUCD as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining Lucid Diagnostics position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 500 Lucid Diagnostics shares in Q3 2022, an estimated $1K.
  • Total Clarity Wealth Management first reported a position in Lucid Diagnostics in Q2 2022 and held it in 1 quarter.
  • Total Clarity Wealth Management's Lucid Diagnostics position peaked at $1K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.